IL17A and amyotrophic lateral sclerosis: The shift toward pro-inflammatory responses in ALS patients, marked by increased Th1 and Th17 cells and reduced Th2 and regulatory T cells, further supports the involvement of IL-17A in neuro-inflammation [130].